The German ADPKD Tolvaptan Treatment Registry
The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.
University of Cologne
2,000 participants
Nov 1, 2015
OBSERVATIONAL
Conditions
Summary
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.
Eligibility
Inclusion Criteria3
- Age \> 18 years
- ADPKD proven by positive family history and evidence of renal cysts or diagnosed by treating physician
- Presentation at our center for tolvaptan treatment indication, or tolvaptan treatment planned, or tolvaptan already started
Exclusion Criteria3
- Patients not capable of giving informed consent
- End stage renal disease requiring renal replacement therapy
- Patients receiving tolvaptan as "off-label use"
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02497521